Hormone receptor and HER-2 expression in breast cancers among sub-Saharan African women

Breast Journal

Volumn 14, Issue 5, 2008, Pages 510-511

  Yarney, Joel ^a,b   Vanderpuye, Verna ^b   Clegg Lamptey, Joe Nat ^b  

^a KORLE BU TEACHING HOSPITAL   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; AFRICA; AGE DISTRIBUTION; AGED; BREAST CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SCORING SYSTEM;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PREVALENCE; PROBABILITY; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 51349102640     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2008.00636.x     Document Type: Letter

References (10)

1. Early Breast Cancer Trialist Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomised trials. Lancet 2005 365 : 1687 717.
2. Slaman DJ, Godolphin W, Jones LA, et al. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science 1989 244 : 707 12.
3. Yamauchi H, Stearns V, Hayes DF. When is a tumour marker ready for primetime? A case study of C-erb B2 as a predictive factor in breast cancer. J Clin Oncol 2001 19 : 2334.
4. Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995 48 : 876 8.
5. Ikpatt OF, Kuopio T, Ndoma-Egba R, et al. Breast cancer in Nigeria and Finland: epidemiology, clinical and histological comparison. Anticancer Res 2002 22 : 3005 12.
6. Newman LA, Bunner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 2002 95 : 21 7.
7. Elledge RM, Clark GM, Charmness GC, et al. Tumour biologic factors and breast cancer prognosis among white, hispanic and black women in the United States. J Natl Cancer Inst 1994 86 : 705 12.
8. Jones BA, Kasi SV, Howe CL, et al. African American/White differences in breast Carcinoma p53 alterations and other tumour characteristics. Cancer 2004 101 : 1293 301.
9. Al-Abbadi MA, Washington TA, Saleh HA, et al. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors. Breast Cancer Res 2006 97 : 3 8.
10. Neven P, Huang HJ, Vanspauwen R, et al. The prognostic and predictive value of the progesterone receptor in women with an oestrogen receptor positive breast cancer. Eur J Cancer 2004 2 : 46 8 (Suppl.; abstract 16).